Glycemic control and cardiovascular risk factor management in adults with type 2 diabetes with and without chronic kidney disease before SGLT2 inhibitors: Insights from the Diabetes Mellitus Status in Canada (DM-SCAN) Survey

2021 ◽  
Author(s):  
Hirmand Nouraei ◽  
Lawrence A. Leiter ◽  
Mary K. Tan ◽  
Anatoly Langer ◽  
Hwee Teoh ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Risk Factor ◽  
Cardiovascular Risk ◽  
Kidney Disease ◽  
Sglt2 Inhibitors ◽  
Risk Factor Management ◽  
Diabetes Mellitus Status

scholarly journals Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus

Circulation ◽  
2019 ◽  
Vol 139 (24) ◽  
pp. 2742-2753 ◽  
Author(s):  
Alison K. Wright ◽  
Evangelos Kontopantelis ◽  
Richard Emsley ◽  
Iain Buchan ◽  
Mamas A. Mamas ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Risk Factor ◽  
Cardiovascular Risk ◽  
Risk Factor Management

Plasma triglycerides as a risk factor for chronic kidney disease in type 2 diabetes mellitus: Evidence from northeastern Thailand

2018 ◽  
Vol 138 ◽  
pp. 238-245 ◽  
Author(s):  
Sojib Bin Zaman ◽  
Mohd Anisul Karim ◽  
Naznin Hossain ◽  
Gulam Muhammed Al Kibria ◽  
Sheikh Mohammed Shariful Islam
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Type 2 Diabetes Mellitus ◽  
Risk Factor ◽  
Kidney Disease ◽  
Plasma Triglycerides ◽  
Northeastern Thailand

1217-P: The Kidney Effects of the SGLT2 Inhibitors on the Japanese Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1217-P
Author(s):  
KAZUO KOBAYASHI ◽  
MASAO TOYODA ◽  
NOBUO HATORI ◽  
HIROYUKI SAKAI ◽  
TAKAYUKI FURUKI ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Type 2 Diabetes Mellitus ◽  
Kidney Disease ◽  
Sglt2 Inhibitors
Sign in / Sign up

Export Citation Format

Share Document